HK1011983A1 - 4-carboxyimidazoles as angiotensin ii antagonists and their thrapeutic use - Google Patents

4-carboxyimidazoles as angiotensin ii antagonists and their thrapeutic use

Info

Publication number
HK1011983A1
HK1011983A1 HK98113196A HK98113196A HK1011983A1 HK 1011983 A1 HK1011983 A1 HK 1011983A1 HK 98113196 A HK98113196 A HK 98113196A HK 98113196 A HK98113196 A HK 98113196A HK 1011983 A1 HK1011983 A1 HK 1011983A1
Authority
HK
Hong Kong
Prior art keywords
antagonists
carboxyimidazoles
thrapeutic
angiotensin
alkyl
Prior art date
Application number
HK98113196A
Other languages
English (en)
Inventor
Hiroaki Yanagisawa
Yasuo Shimoji
Yoshiya Amomiya
Takuro Kanazaki
Hiroyuki Koike
Toshio Sada
Original Assignee
Sankyo Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sankyo Co filed Critical Sankyo Co
Publication of HK1011983A1 publication Critical patent/HK1011983A1/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
    • C07D403/10—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a carbon chain containing aromatic rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
    • C07D233/66—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D233/90—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/14—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing three or more hetero rings
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00—Technologies relating to chemical industry
    • Y02P20/50—Improvements relating to the production of bulk chemicals
    • Y02P20/55—Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
HK98113196A 1992-06-02 1998-12-11 4-carboxyimidazoles as angiotensin ii antagonists and their thrapeutic use HK1011983A1 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP14116092 1992-06-02

Publications (1)

Publication Number Publication Date
HK1011983A1 true HK1011983A1 (en) 1999-07-23

Family

ID=15285532

Family Applications (1)

Application Number Title Priority Date Filing Date
HK98113196A HK1011983A1 (en) 1992-06-02 1998-12-11 4-carboxyimidazoles as angiotensin ii antagonists and their thrapeutic use

Country Status (22)

Country Link
EP (1) EP0573218B1 (de)
JP (1) JP3461863B2 (de)
KR (1) KR100300473B1 (de)
CN (1) CN1051766C (de)
AT (1) ATE199548T1 (de)
AU (1) AU661153B2 (de)
CA (1) CA2097444C (de)
CZ (1) CZ287764B6 (de)
DE (1) DE69329982T2 (de)
DK (1) DK0573218T3 (de)
ES (1) ES2155827T3 (de)
FI (1) FI112476B (de)
GR (1) GR3035624T3 (de)
HK (1) HK1011983A1 (de)
HU (1) HUT64329A (de)
IL (1) IL105825A (de)
NO (1) NO303872B1 (de)
NZ (1) NZ247750A (de)
PT (1) PT573218E (de)
RU (1) RU2086541C1 (de)
TW (1) TW228521B (de)
ZA (1) ZA933824B (de)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AT398202B (de) * 1991-10-04 1994-10-25 Chem Pharm Forsch Gmbh Neue imidazolderivate, verfahren zu ihrer herstellung und ihre verwendung
US5310929A (en) * 1992-08-06 1994-05-10 E. I. Du Pont De Nemours And Company Prodrugs of imidazole carboxylic acids as angiotensin II receptor antagonists
JP3501484B2 (ja) * 1992-12-17 2004-03-02 三共株式会社 ビフェニル誘導体
NZ282485A (en) * 1994-03-16 1997-06-24 Sankyo Co Treatment of ocular hypertension using imidazole derivatives
KR100428725B1 (ko) * 1996-03-30 2004-07-07 주식회사 현대시스콤 디지탈이동통신교환기녹음안내장치의2단계자체루프백시험장치및방법
GR20000100281A (el) * 2000-08-17 2002-05-24 Ιωαννης Ματσουκας Ανταγωνιστες του υποδοχεα της αγγεοτενσινης ιι και συνθετικες μεθοδοι για την θεραπεια της υπερτασης και καρδιοαγγειακων ασθενειων
CN1197866C (zh) * 2003-03-21 2005-04-20 上海医药工业研究院 4，6－二氢呋喃并[3,4－d]咪唑－6－酮衍生物及其盐和制备方法
TWI349549B (en) * 2003-04-15 2011-10-01 Sankyo Co Medicament for treatment of intraocular angiopoietic disease
EP1713795A2 (de) 2004-02-11 2006-10-25 Teva Pharmaceutical Industries Ltd. Candesartan-cilexetil-polymorphe
CN101024643A (zh) * 2006-02-20 2007-08-29 上海艾力斯医药科技有限公司 咪唑－5－羧酸类衍生物、制备方法及其应用
TWI448284B (zh) * 2007-04-24 2014-08-11 Theravance Inc 雙效抗高血壓劑
US20110224271A1 (en) * 2007-08-08 2011-09-15 Lek Pharmaceuticals D.D. process for the preparation of olmesartan medoxomil
CN101481374B (zh) * 2008-01-09 2013-01-09 浙江华海药业股份有限公司 1-三苯甲基-5-(1，1｀-联苯基-2基)-1h-四唑类化合物脱去三苯甲基的方法
CN103319461A (zh) * 2013-07-02 2013-09-25 临海天宇药业有限公司 奥美沙坦酯中间体的制备方法以及奥美沙坦酯的合成方法
CN104262332A (zh) * 2014-09-16 2015-01-07 上海信谊百路达药业有限公司 一种奥美沙坦酯的制备方法
CN104356069B (zh) * 2014-11-18 2016-09-14 黄冈鲁班药业有限公司 奥美沙坦酯中间体4-(1-羟基-1-甲基乙基)-2-丙基咪唑-5-羧酸乙酯的制备方法及应用

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA1334092C (en) * 1986-07-11 1995-01-24 David John Carini Angiotensin ii receptor blocking imidazoles
CA1338238C (en) * 1988-01-07 1996-04-09 David John Carini Angiotensin ii receptor blocking imidazoles and combinations thereof with diuretics and nsaids
WO1991000277A1 (en) * 1989-06-30 1991-01-10 E.I. Du Pont De Nemours And Company Substituted imidazoles
IL98319A (en) * 1990-07-05 1997-04-15 Roussel Uclaf Sulphurous derivatives of imidazole, their preparation process, and pharmaceutical compositions containing them
CA2229000C (en) * 1991-02-21 2002-04-09 Sankyo Company, Limited 1-biphenylimidazole derivatives, their preparation and their therapeutic use
EP0505098A1 (de) * 1991-03-19 1992-09-23 Merck & Co. Inc. Imidazolderivate mit funktionelle Säuregruppen als Angiotensin-II-Antagoniste

Also Published As

Publication number Publication date
CN1051766C (zh) 2000-04-26
CA2097444A1 (en) 1993-12-03
EP0573218A3 (en) 1994-06-01
DE69329982D1 (de) 2001-04-12
AU3988093A (en) 1993-12-09
FI932492A (fi) 1993-12-03
IL105825A (en) 1998-01-04
CZ105093A3 (en) 1993-12-15
KR940000455A (ko) 1994-01-03
NO303872B1 (no) 1998-09-14
FI932492A0 (fi) 1993-06-01
IL105825A0 (en) 1993-09-22
PT573218E (pt) 2001-06-29
TW228521B (de) 1994-08-21
ZA933824B (en) 1993-12-27
CA2097444C (en) 2005-03-29
EP0573218B1 (de) 2001-03-07
DK0573218T3 (da) 2001-06-18
JP3461863B2 (ja) 2003-10-27
KR100300473B1 (ko) 2002-01-09
RU2086541C1 (ru) 1997-08-10
ATE199548T1 (de) 2001-03-15
JPH0649036A (ja) 1994-02-22
NZ247750A (en) 1995-05-26
GR3035624T3 (en) 2001-06-29
AU661153B2 (en) 1995-07-13
NO931980D0 (no) 1993-06-01
CZ287764B6 (en) 2001-01-17
ES2155827T3 (es) 2001-06-01
HU9301600D0 (en) 1993-09-28
HUT64329A (en) 1993-12-28
DE69329982T2 (de) 2001-09-27
NO931980L (no) 1993-12-03
EP0573218A2 (de) 1993-12-08
FI112476B (fi) 2003-12-15
CN1085896A (zh) 1994-04-27

Similar Documents

Publication Publication Date Title
EP0573218A3 (en) 4-carboxyimidazoles as angiotensin ii antagonists and their thrapeutic use
HK1073460A1 (en) Substituted 1, 3-oxathiolanes with antiviral properties
AU6601294A (en) Amide and urea derivatives having anti-hypercholesteremic activity, their preparation and their therapeutic uses
TR199801642T2 (xx) Tedavide faydal� olan karbamik asitlerin azabisiklik esterleri.
IE891963L (en) Method of treating cachexia and certain new compounds for¹use in this method
SI0688771T1 (en) Use of lactam compounds as pharmaceutical agents
WO1994003425A3 (en) Carbostyril derivatives for the treatment of arrhythmia
AU8982791A (en) Pharmaceutically active phenylalkylamino-alkyl compounds
IL92648A0 (en) Substituted benzoic acid esters and pharmaceutical compositions containing them
ES8704940A1 (es) Procedimiento de preparacion de nuevos derivados alquilamino-furanonas y de sales y diastereoisomeros farmaceuticamente aceptables de los mismos.
MX9705648A (es) Empleo dermatologico de derivados de vitamina d.

Legal Events

Date Code Title Description
PF Patent in force
PC Patent ceased (i.e. patent has lapsed due to the failure to pay the renewal fee)

Effective date: 20050527